
CPRI
20.16 USD
-0.40%
Today
-0.45%
1D
Market is closed
Sun
Closed
Mon
4:30 PM ~ 10:59 PM
Tue
4:30 PM ~ 10:59 PM
Wed
4:30 PM ~ 10:59 PM
Thu
4:30 PM ~ 10:59 PM
Fri
4:30 PM ~ 10:59 PM
Sat
Closed
Information
Name
Capri
Currency
USD
Market Cap
479.07M
Avg Daily Volume
5.92M
52 Week High
40.37 USD
52 Week Low
2.96 USD
Trading Hours
See hours
Business Summary
Capricor Therapeutics, Inc., a clinical-stage biotechnology company, engages in the development of transformative cell and exosome-based therapeutics for treating duchenne muscular dystrophy (DMD) and other diseases with unmet medical needs in the United States. Its lead product candidate is the Deramiocel, an allogeneic cardiosphere-derived cells, which is in phase 3 clinical trial for the treatment of DMD. The company also develops Exosome protein-based vaccine, which is in preclinical trial to treat SARS-CoV-2; StealthX Exosome Platform, and exosome platform program consists of engineered exosomes for vaccine and therapeutic development and is in preclinical trial. In addition, it engages in developing StealthX, an engineered exosome-based vaccine candidate, under phase 1 clinical study for a range of therapeutic applications, including targeted RNA, protein, and small molecule therapeutics to treat or prevent a variety of diseases; It has license agreement with Johns Hopkins University, University of Rome License, and Cedars-Sinai Medical Center to develop and commercialize licensed products and licensed services under the licensed patent rights in all fields and a nonexclusive right to the know-how; Cell Line License Agreement with Life Technologies for the development of exosomes platform. The company was founded in 2005 and is headquartered in San Diego, California.
Top News
Capri
+0.65%
Capri Holdings (CPRI) Plans 50 To 75 New Stores
finance.yahoo.com
4h ago

Capri
+0.65%
Capri Holdings (CPRI) Stock Looks Like A Bargain On Its 69% Slide
finance.yahoo.com
6h ago

Capri
+0.65%
Capricor Therapeutics, Inc. Stock 12‑Month Price Target Raised to $27, Implies 228% Upside
tradingview.com
7h ago

Show more
Frequently Asked Questions
What are cyclical stocks in trading?
Cyclicals are stocks that move in line with the broader economy. They perform well during economic booms and tend to decline during recessions.
Why do traders invest in cyclical sectors?
Traders use cyclicals to capitalize on economic recovery phases, often seeking high returns when consumer spending and business investment rise.
What industries fall under cyclicals?
Automobiles, travel & tourism, retail, restaurants, and luxury goods are common cyclical industries.
Are cyclical stocks risky?
They can be. While they offer growth potential, they are more volatile and sensitive to economic changes compared to defensive sectors.

